bioRxiv · 10.1101/2025.01.22.634271
17β-Estradiol Counteracts Pathological Microtubule Remodeling To Enhance Cardiac Function
Abstract
The female-predominate sex hormone 17{beta}-estradiol exerts cardioprotective effects via multiple mechanisms. Available data demonstrate 17{beta}-estradiol modulates microtubule dynamics in vitro, but its effects on pathogenic microtubule remodeling in pressure-overloaded cardiomyocytes are unexplored. Here, we show 17{beta}-estradiol directly blunts microtubule polymerization in vitro, counteracts endothelin-mediated microtubule remodeling in iPSC-cardiomyocytes, and mitigates microtubule stabilization in pulmonary artery banded right ventricular cardiomyocytes. 17{beta}-estradiol treatment blunts cardiomyocyte and nuclear hypertrophy, restores t-tubule architecture, and prevents mislocalization of connexin-43 in RV cardiomyocytes of pulmonary artery banded rats. These cellular phenotypes are paired with significant improvements in RV function. Thus, we propose 17{beta}-estradiol exerts cardioprotective effects via direct modulation of microtubules in addition to its well ascribed signaling functions.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Moon, R., Vogel, N., Mendelson, J. B., Hartweck, L., Carney, J., Kim, M., Gardner, M. K., Prisco, S., Prins, K.. 2025-01-24. 17β-Estradiol Counteracts Pathological Microtubule Remodeling To Enhance Cardiac Function. https://doi.org/10.1101/2025.01.22.634271
Cite the original work for its findings. Save a collection to share your selection of sources.